A 69-year-old female patient presented with a 5.8 cm thoracoabdominal aortic aneurysm Crawford type II after partial arch replacement. She was treated by a branched thoracic endovascular aortic repair procedure using a branched arch endograft with one retrograde branch to the left subclavian artery. After deployment of a Viabahn as a bridging covered stent to the left subclavian artery, the deployment line did not detach and the delivery catheter could not be removed. With the use of a physician-modified sidehole catheter and balloon fixation, the pulling line could be released without displacement of the Viabahn endoprosthesis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515410 | PMC |
| http://dx.doi.org/10.1016/j.jvscit.2021.06.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cangrelor Use for Viabahn Stent Graft Patency as Bridge to Coronary Artery Bypass Graft Surgery.
J Pharm Pract
January 2025
Department of Cardiothoracic Surgery, Jefferson Health Abington Hospital, Abington, PA, USA.
Article Synopsis
- Utilization of cangrelor as a bridging therapy to cardiac surgery has been noted for stent placement, but less so for endovascular revascularization.
- The case involves a 47-year-old female with a significant arterial dissection requiring a Viabahn endoprosthesis and subsequent cardiac procedures.
- A combination of cangrelor, aspirin, and bivalirudin was employed to manage the patient’s coronary disease and ensure the effectiveness of the surgical intervention, showcasing a multi-disciplinary approach in complex cases.
Mid-Term Outcomes of the Viabahn Balloon-Expandable Endoprosthesis as Bridging Stent Graft for Fenestrated and Branched Endovascular Aortic Repair.
J Endovasc Ther
November 2024
Department of Surgery, Amsterdam University Medical Centers, Location Vrije Universiteit, Amsterdam, The Netherlands.
Article Synopsis
- * Methods: Researchers reviewed data from patients who received VBX stent grafts during F/B-EVAR between January 2019 and May 2023, focusing on technical success, potential complications, and overall patient survival.
- * Results: The study found a 97.5% technical success rate for VBX stent graft implantation, with low rates of complications and high overall survival at 86.7% after
Laser Atherectomy and Restenting of the Superficial Femoral Artery Using GORE VIABAHN Endoprosthesis Following Failure of Both Bare-Metal Stenting and Surgical Revascularization.
Case Rep Vasc Med
November 2024
Department of Cardiology, Methodist Le Bonheur Healthcare, Memphis, Tennessee, USA.
Peripheral arterial disease (PAD) affects more than 230 million adults worldwide. Revascularization via angioplasty is a common method to manage stenosis in the superficial femoral artery (SFA). In-stent restenosis, however, is a common complication in endovascular interventions, especially in the SFA.
View Article and Find Full Text PDFArticle Synopsis
- * A total of 103 patients, mostly with stenotic issues in the upper arm, showed high technical and clinical success rates, with favorable patency rates at 6 months.
- * The research found low rates of adverse events (≤3%) and no device deficiencies, supporting the use of this stent graft as a safe and effective option for patients experiencing vascular access graft problems.
A three-year experience with the balloon expandable GORE VIABAHN VBX in the treatment of thoraco-abdominal aortic aneurysms within the EXPAND trial.
J Vasc Surg
February 2025
Department of Vascular Surgery, St. Franziskus Hospital, Münster, Germany.
Article Synopsis
- The EXPAND registry evaluates the safety and performance of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX stent) for use in peripheral vessels, focusing on its effectiveness as a bridging stent during branched endovascular aortic repair (BEVAR).
- A three-year study involved 73 patients from 16 European sites, assessing the primary and secondary patency rates, among other factors, revealing a high success rate with 93.6% primary patency across treated target vessels.
- Results indicated that while the VBX stent showed excellent long-term outcomes (94% primary and 97% secondary patency), patency rates were lower in renal arteries compared to other
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!